Source: MarketScreener

BDSI: SHAREHOLDER ALERT: WeissLaw LLP Investigates BioDelivery Sciences International, Inc.

(marketscreener.com) NEW YORK, Feb. 15, 2022 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of BioDelivery Sciences International, Inc. , in connection with the proposed acquisition of the Company by Collegium Pharmaceutical, Inc. via a tender offer. Under the...https://www.marketscreener.com/quote/stock/COLLEGIUM-PHARMACEUTICAL-22148971/news/SHAREHOLDER-ALERT-WeissLaw-LLP-Investigates-BioDelivery-Sciences-International-Inc-39480863/?utm_medium=RSS&utm_content=20220215

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
100-250
Jeffrey A. Bailey's photo - CEO of BDSI

CEO

Jeffrey A. Bailey

CEO Approval Rating

87/100

Read more